ODDB.org: Open Drug Database

Wellvone, Suspension - 210 ml

Swissmedic Key	53563015	Registration Holder	GlaxoSmithKline AG
Name	Wellvone, Suspension	Date of registration	29.05.1996
		Introduction of Sequence	29.05.1996
ATC-Classification	Atovaquone (P01AX06)	Revision date	30.01.2006
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	08.04.30.	Show package size	210 ml
Index Therapeuticus (Swissmedic)	08.04.30.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	432.15	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	486.40
Feedback	FB	Daily cost
GTIN	7680535630151	Medication Code	Synthetika
Pharmacode	1726288	Disponibility

Composition

atovaquonum 750 mg, alcohol benzylicus 50 mg, xanthani gummi, poloxamerum 188, saccharinum natricum corresp. natrium 0.95 mg, aromatica (Vielfrucht) cum aurantii dulcis aetheroleum, aurantii dulcis aetheroleum concentratum, propylenglycolum, alcohol benzylicus 0.66 mg, vanillinum, acetaldehydum, ethylis butyras et amylis acetas, aqua purificata q.s. ad suspensionem pro 5 ml.

Packungsbestandteile

Galenic Form

Suspension

Excipiens

Active Agent	Dose
Atovaquone	750mg / 5ml

BAG: Active Agent	Dose
Atovaquone	750 mg

Inactive agents	Dose
Acetaldehydum
Alcohol Benzylicus	0.66mg / 5ml
Amylis Acetas
Aqua Purificata
Aromatica (Vielfrucht) cum Aurantii Dulcis Aetheroleum
Aurantii Dulcis Aetheroleum Concentratum
Ethylis Butyras
Poloxamer	188
Propylenglycol
Saccharinum Natricum
Vanilline
Xanthani Gummi

Source

Data was imported : 06.10.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH